[1]
A. R. Alvarez Crespo, L. Alonso Carbonell, I. B. Yara Alos, A. J. Garcia Milian, y M. A. Marrero Miragaya, «Characterization of adverse events during the treatment with heberprot-p® in four cuban provinces», HS, vol. 14, n.º 2, pp. 42–46, sep. 2015, doi: 10.19136/hs.a14n2.950.